Correlation Between Apellis Pharmaceuticals and Ocuphire Pharma
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Ocuphire Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Ocuphire Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Ocuphire Pharma, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Ocuphire Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Ocuphire Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Ocuphire Pharma.
Diversification Opportunities for Apellis Pharmaceuticals and Ocuphire Pharma
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Apellis and Ocuphire is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Ocuphire Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ocuphire Pharma and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Ocuphire Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ocuphire Pharma has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Ocuphire Pharma go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and Ocuphire Pharma
If you would invest 2,726 in Apellis Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of 667.00 from holding Apellis Pharmaceuticals or generate 24.47% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 4.76% |
| Values | Daily Returns |
Apellis Pharmaceuticals vs. Ocuphire Pharma
Performance |
| Timeline |
| Apellis Pharmaceuticals |
| Ocuphire Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Apellis Pharmaceuticals and Ocuphire Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apellis Pharmaceuticals and Ocuphire Pharma
The main advantage of trading using opposite Apellis Pharmaceuticals and Ocuphire Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Ocuphire Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocuphire Pharma will offset losses from the drop in Ocuphire Pharma's long position.| Apellis Pharmaceuticals vs. Tff Pharmaceuticals | Apellis Pharmaceuticals vs. Eliem Therapeutics | Apellis Pharmaceuticals vs. Inhibrx | Apellis Pharmaceuticals vs. Enliven Therapeutics |
| Ocuphire Pharma vs. Reviva Pharmaceuticals Holdings | Ocuphire Pharma vs. Protalix Biotherapeutics | Ocuphire Pharma vs. Eyepoint Pharmaceuticals | Ocuphire Pharma vs. Sellas Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |